Discover the full directors' dealings record of Pennant Group, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Pennant Group, Inc. has logged 72 public disclosures. Market capitalisation: €1.2bn. The latest transaction was disclosed on 17 April 2026 — Attribution. Among the most active insiders: Christensen Christopher R.. The full history is openly available.
0 of 0 declarations
The Pennant Group, Inc. (ticker: PNTG) is a U.S.-listed healthcare services company traded on NASDAQ in the United States. For French-speaking investors, Pennant is best understood as a specialized post-acute care platform built around independently operated subsidiaries. Its core business is organized into three main service lines: home health, hospice, and senior living communities. Based on the company’s investor materials and 2025 annual report, Pennant operates more than 120 home health and hospice agencies and more than 50 senior living communities across a broad multi-state footprint, including Arizona, California, Colorado, Idaho, Nevada, Oregon, Texas, Utah, Washington, Wisconsin, and other states in the American West and Midwest. The company’s headquarters are in Eagle, Idaho, underscoring its operational base in the western United States. Pennant was formed in 2019 as a growth platform in healthcare services, and its model is built on acquiring and developing local operating businesses while preserving a decentralized management structure. Each subsidiary is run with its own management team, employees, and assets, which is a notable feature of the group’s operating philosophy. From a competitive standpoint, Pennant is not a hospital operator or a diversified managed-care giant; rather, it competes in fragmented local markets where execution, care quality, census growth, and operational discipline are key value drivers. This makes the stock particularly relevant for investors seeking exposure to non-acute healthcare delivery, demographic tailwinds, and acquisition-driven growth. Recent company updates have reinforced that narrative. Pennant reported first-quarter 2026 results in early May 2026 and announced acquisitions of senior living communities in Arizona and Wisconsin, signaling continued expansion through M&A. In November 2025, the company also expanded its credit facility by $100 million to a total of $350 million, improving financial flexibility and providing additional capacity to support growth initiatives. Overall, PNTG is a NASDAQ-listed U.S. healthcare company with a focused footprint, a decentralized operating model, and a strategy centered on growth in home health, hospice, and senior living services.